# Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia

> **NCT04742101** · PHASE1,PHASE2 · COMPLETED · sponsor: **Institut de Recherches Internationales Servier** · enrollment: 57 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** S65487 and azacitidine

## Key facts

- **NCT ID:** NCT04742101
- **Lead sponsor:** Institut de Recherches Internationales Servier
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-10
- **Primary completion:** 2026-03-27
- **Final completion:** 2026-03-27
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2026-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04742101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04742101, "Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-09-01 from https://api.ai-analytics.org/clinical/NCT04742101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*